BR112012029458A2 - processo aperfeiçoado para um agente de folato alvejado - Google Patents

processo aperfeiçoado para um agente de folato alvejado

Info

Publication number
BR112012029458A2
BR112012029458A2 BR112012029458A BR112012029458A BR112012029458A2 BR 112012029458 A2 BR112012029458 A2 BR 112012029458A2 BR 112012029458 A BR112012029458 A BR 112012029458A BR 112012029458 A BR112012029458 A BR 112012029458A BR 112012029458 A2 BR112012029458 A2 BR 112012029458A2
Authority
BR
Brazil
Prior art keywords
streamlined process
targeted
folate agent
targeted folate
agent
Prior art date
Application number
BR112012029458A
Other languages
English (en)
Portuguese (pt)
Inventor
Daniel S Reno
Iontcho Radoslavov Vlahov
Katheryn Marie Stanford
Original Assignee
Endocyte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Endocyte Inc filed Critical Endocyte Inc
Publication of BR112012029458A2 publication Critical patent/BR112012029458A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A61K47/551—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug one of the codrug's components being a vitamin, e.g. niacinamide, vitamin B3, cobalamin, vitamin B12, folate, vitamin A or retinoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112012029458A 2010-05-19 2011-05-19 processo aperfeiçoado para um agente de folato alvejado BR112012029458A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34644410P 2010-05-19 2010-05-19
US35102210P 2010-06-03 2010-06-03
PCT/US2011/037134 WO2011146707A1 (en) 2010-05-19 2011-05-19 Improved process for a folate-targeted agent

Publications (1)

Publication Number Publication Date
BR112012029458A2 true BR112012029458A2 (pt) 2015-10-20

Family

ID=44992057

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012029458A BR112012029458A2 (pt) 2010-05-19 2011-05-19 processo aperfeiçoado para um agente de folato alvejado

Country Status (11)

Country Link
US (2) US20130065841A1 (cg-RX-API-DMAC7.html)
JP (1) JP2013526577A (cg-RX-API-DMAC7.html)
KR (1) KR20130079431A (cg-RX-API-DMAC7.html)
CN (1) CN102984943B (cg-RX-API-DMAC7.html)
BR (1) BR112012029458A2 (cg-RX-API-DMAC7.html)
CA (1) CA2799391A1 (cg-RX-API-DMAC7.html)
IL (1) IL222964A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012013250A (cg-RX-API-DMAC7.html)
RU (1) RU2012154914A (cg-RX-API-DMAC7.html)
SG (1) SG185592A1 (cg-RX-API-DMAC7.html)
WO (1) WO2011146707A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107847609A (zh) 2015-03-13 2018-03-27 恩多塞特公司 用于治疗疾病的缀合物
WO2017172930A1 (en) * 2016-03-29 2017-10-05 Endocyte, Inc. Pbd conjugates for treating diseases
WO2019196999A1 (en) 2018-04-11 2019-10-17 Radisurf Aps Compositions for forming polymer brushes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101239190B (zh) * 2003-01-27 2013-09-25 恩多塞特公司 维生素受体结合递药缀合物
CN100423778C (zh) * 2003-11-25 2008-10-08 上海复旦张江生物医药股份有限公司 用于上载抗肿瘤药物的脂质体载体及其制备方法和应用
JP2009504783A (ja) * 2005-08-19 2009-02-05 エンドサイト,インコーポレイテッド ビンカアルカロイド、類似体および誘導体のリガンド結合体

Also Published As

Publication number Publication date
US20140066593A1 (en) 2014-03-06
US20130065841A1 (en) 2013-03-14
RU2012154914A (ru) 2014-06-27
KR20130079431A (ko) 2013-07-10
SG185592A1 (en) 2012-12-28
CN102984943A (zh) 2013-03-20
MX2012013250A (es) 2013-03-05
WO2011146707A1 (en) 2011-11-24
CN102984943B (zh) 2016-01-13
IL222964A0 (en) 2013-02-03
CA2799391A1 (en) 2011-12-04
JP2013526577A (ja) 2013-06-24

Similar Documents

Publication Publication Date Title
BR112014005322A2 (pt) processo
ES2829950T8 (es) Procedimiento para producir componentes endurecidos
BR112013025228A2 (pt) processo para fabricar conjugados de homogeneidade aperfeçoada
BR112013033322A2 (pt) processo para produzir derivados de quitina
BR112013018679A2 (pt) agente para o tratamento da alopecia
BR112014016000A2 (pt) processo
BR112014029236A2 (pt) processo de hidroprocessamento
BR112014008671A2 (pt) processo de preparação de abiraterona
BR112014016001A8 (pt) processo
BR112013012873A2 (pt) processo para preparar uma n, n-dialquiletanolamina
BR112013008883A2 (pt) processo para a fabricação de di-hidropteridinonas
BR112014015988A8 (pt) processo
BR112012028562A2 (pt) processo para o revestimento de tecidos
PT2892862T (pt) Processo para a redução de derivados de nitro em aminas
BR112013033184A2 (pt) processo
BR112015004829A2 (pt) método para a cimentação dentro de locais confinados
BR112014015999A8 (pt) processo
BR112013004660A2 (pt) espessante associativo para soluções aquosas
BR112012024474A2 (pt) processo
BR112012031566A2 (pt) método de alisamento do cabelo
BR112012029016A2 (pt) processo de redução direta
BR112015000987A2 (pt) processo para a preparação de 5-fluoro-1h-pirazóis
BR112012021379A2 (pt) processo para a preparação de um alqueno
BR112014018038A2 (pt) processo para fabricação de cateteres urinários
BR112014002093A2 (pt) processo para a formação de um polímero

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.